US12239374B2 - Method of manufacturing a tear flow measurement device - Google Patents
Method of manufacturing a tear flow measurement device Download PDFInfo
- Publication number
- US12239374B2 US12239374B2 US18/344,118 US202318344118A US12239374B2 US 12239374 B2 US12239374 B2 US 12239374B2 US 202318344118 A US202318344118 A US 202318344118A US 12239374 B2 US12239374 B2 US 12239374B2
- Authority
- US
- United States
- Prior art keywords
- capillary tube
- tube
- hydrophobic
- tear
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000005259 measurement Methods 0.000 title claims abstract description 31
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 44
- 239000007788 liquid Substances 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 39
- 229920000642 polymer Polymers 0.000 claims abstract description 34
- 229920002379 silicone rubber Polymers 0.000 claims abstract description 22
- 239000004945 silicone rubber Substances 0.000 claims abstract description 22
- 230000007935 neutral effect Effects 0.000 claims abstract description 14
- 238000000576 coating method Methods 0.000 claims description 14
- 230000028327 secretion Effects 0.000 claims description 14
- 239000011248 coating agent Substances 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 229920000052 poly(p-xylylene) Polymers 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- 230000001590 oxidative effect Effects 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 238000011010 flushing procedure Methods 0.000 claims description 5
- 238000004804 winding Methods 0.000 claims description 5
- BLIQUJLAJXRXSG-UHFFFAOYSA-N 1-benzyl-3-(trifluoromethyl)pyrrolidin-1-ium-3-carboxylate Chemical compound C1C(C(=O)O)(C(F)(F)F)CCN1CC1=CC=CC=C1 BLIQUJLAJXRXSG-UHFFFAOYSA-N 0.000 claims description 4
- 239000012530 fluid Substances 0.000 abstract description 19
- 230000007774 longterm Effects 0.000 abstract description 9
- 238000012360 testing method Methods 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract description 2
- 238000005303 weighing Methods 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 description 34
- 210000002381 plasma Anatomy 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- 210000000744 eyelid Anatomy 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- 239000004696 Poly ether ether ketone Substances 0.000 description 6
- 229920002530 polyetherether ketone Polymers 0.000 description 6
- -1 polyethylene Polymers 0.000 description 6
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 5
- 206010013774 Dry eye Diseases 0.000 description 5
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 230000005661 hydrophobic surface Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000005499 meniscus Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- VRBFTYUMFJWSJY-UHFFFAOYSA-N 28804-46-8 Chemical compound ClC1CC(C=C2)=CC=C2C(Cl)CC2=CC=C1C=C2 VRBFTYUMFJWSJY-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 239000000607 artificial tear Substances 0.000 description 2
- 229920000249 biocompatible polymer Polymers 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 238000003618 dip coating Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000379 polypropylene carbonate Polymers 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000004489 tear production Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 231100001032 irritation of the eye Toxicity 0.000 description 1
- 210000004561 lacrimal apparatus Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004083 nasolacrimal duct Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000003075 superhydrophobic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- IGELFKKMDLGCJO-UHFFFAOYSA-N xenon difluoride Chemical compound F[Xe]F IGELFKKMDLGCJO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/101—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for examining the tear film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6821—Eye
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
- G01F22/00—Methods or apparatus for measuring volume of fluids or fluent solid material, not otherwise provided for
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01G—WEIGHING
- G01G19/00—Weighing apparatus or methods adapted for special purposes not provided for in the preceding groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
- G01N1/14—Suction devices, e.g. pumps; Ejector devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/4875—Details of handling test elements, e.g. dispensing or storage, not specific to a particular test method
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
- A61B2010/0067—Tear or lachrymal fluid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01G—WEIGHING
- G01G17/00—Apparatus for or methods of weighing material of special form or property
- G01G17/04—Apparatus for or methods of weighing material of special form or property for weighing fluids, e.g. gases, pastes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/02—Devices for withdrawing samples
- G01N1/10—Devices for withdrawing samples in the liquid or fluent state
- G01N1/14—Suction devices, e.g. pumps; Ejector devices
- G01N2001/1472—Devices not actuated by pressure difference
- G01N2001/149—Capillaries; Sponges
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
Definitions
- Most common treatments for dry eye include: i) administration of artificial tears/medications/ointments, and/or ii) a punctal occlusion with a plug that cause the tears to remain in the eye longer.
- Schirmer's test involves holding an absorbent filter paper strip to the lacrimal lake of a subject's eye. It is kept there for upwards of five minutes. Liquid wicks its way up the strip, turning the strip a slightly different color from the wetness. The farther the liquid creeps, the moister the eye. Commonly, young people moisten the strip about 15 mm, while elderly people moisten only 10 mm.
- the Schirmer test has not improved much for over a century. This is unfortunately because it has its drawbacks.
- the touch of paper to one's eye sometimes causes irritation and reactive tears in response. This results in a reading that is too high.
- a topical anesthetic may be applied. But then the anesthetic may affect the tear flow measurement results.
- the filter paper used for Schirmer strips largely composed of randomly sized interstitial spaces between fibers.
- One piece of paper may transport liquid faster or in greater quantities than another piece of paper. That is, calibration between strips is an issue.
- An entire inner surface of the polymer capillary tube could have been a hydrophilic or neutral hydrophile surface before the hydrophobic treating.
- the method can include modifying a remainder of the inner surface extending to the entrance end of the capillary tube to be hydrophilic by exposing to oxygen plasma or flushing with an oxidizing acid.
- the hydrophobic treating includes a treatment selected from the group consisting of coating with parylene HT, exposing to xenon difluoride or silanating gas, and treating with plasma.
- the method can include forming a bypass channel extending from the entrance end and around an outside of the capillary tube to the exit end, the bypass channel configured to allow a predetermined ratio of liquid to bypass the polymer capillary tube.
- Some embodiments are related to a method of measuring tear secretion, the method including providing a polymer capillary tube having an inner diameter between 1 micron to 1000 microns ( ⁇ m), the capillary tube having a hydrophobic inner surface localized at an exit end of the capillary tube and a hydrophilic or neutral hydrophile inner surface throughout a remainder of the capillary tube extending to an entrance end of the capillary tube, contacting the entrance end to a lacrimal lake of a subject's eye, waiting for tear liquid from the lacrimal lake to be drawn into the capillary tube, and measuring an amount of tear liquid that was drawn into the capillary tube.
- Measuring the amount can include determining a volume of or weighing the drawn tear liquid.
- the method can include performing liquid chromatography on the drawn tear liquid.
- FIG. 1 A illustrates a tear secretion measurement device having a silicone rubber covering along its entire length in accordance with an embodiment.
- FIG. 1 B illustrates a longitudinal cross section of the device of FIG. 1 A .
- FIG. 2 B illustrates a longitudinal cross section of the device of FIG. 2 A .
- FIG. 3 illustrates a bypass channel to a tear secretion measurement device and cross section cutout in accordance with an embodiment.
- FIG. 4 illustrates a coiled tear measurement device on an eye in accordance with an embodiment.
- FIG. 5 illustrates a broad internal reservoir device on an eye in accordance with an embodiment.
- FIG. 6 is a cut out section of the device of FIG. 5 .
- FIG. 8 is a flowchart illustrating a process in accordance with an embodiment.
- tear flow measurement devices are described in which an end of a small tube with an inner diameter between 1 micron to 1000 microns ( ⁇ m) has been treated to be hydrophobic. At that scale, forces between the hydrophobic surface and the liquid meniscus dominate other forces and determines whether liquid is held back or passes. While allowing gaseous air to pass, the hydrophobic treatment holds back liquid inside the tube from exiting and prevents liquid from outside entering the exit end.
- the soft coating may also be slipped over the device.
- the tube with the soft coating is chosen to have an inner diameter identical or slightly smaller than the outer diameter of the device.
- This soft tube (coating) is first soaked in a compatible organic solvent, such as isopropanol, acetone, or hexane, to cause the soft tube to swell.
- a compatible organic solvent such as isopropanol, acetone, or hexane
- capillary tube 106 The entire outer circumference of capillary tube 106 is coated with silicone rubber covering 108 , from entrance end 102 to exit end 104 .
- the covering was formed by taking a pre-formed silicone rubber tube, expanding it by having it absorb a liquid, inserting the polymer capillary through one end, then allowing the liquid to evaporate.
- the silicone rubber tube shrinks when the liquid within it evaporates out. In this case, the shrinking makes a tight fit around the outer circumference of the capillary tube.
- Another process for soft coating is to place the device in a large mold to over-mold the soft silicone coating.
- Capillary tube 106 has inner surface 113 extending from entrance end 102 to exit end 104 . Localized near exit end 104 , the inner surface is hydrophobic inner surface 114 . The localized section extends a length 116 from exit end 104 into the tube. The length can be between 2 millimeters to 50 millimeters (mm), 100 mm, 150 mm, 200 mm, 300 mm, 400 mm, 500 mm, or other lengths in accordance with the required reservoir volume for storing tear fluid.
- the capillary tube is not shown to scale in the figure.
- the inner surface of a tube can be made hydrophobic by coating it with parylene-HT, which is inherently hydrophobic.
- the length of the coated region can be controlled by warming or cooling the device during the deposition. It is thought that the temperature of the device changes the mobility of the parylene monomer before polymerization on its surface.
- the surface may also be made hydrophobic by exposure to XeF 2 gas or silanating gases such as hexamethyldisilazane (HMDS).
- HMDS hexamethyldisilazane
- Oxygen plasma breaks bonds in polymers and oxidizes the surface.
- the resultant surface forms a hydroxyl layer in contact with the air, which is hydrophilic. This effect is magnified by the roughening impact of oxygen plasma.
- the inner surface of the tube may also be flushed with an oxidizing acid such as nitric acid, or nitric acid in combination with hydrogen peroxide. This flush will oxidize the surface and result in a hydroxyl layer similar to oxygen plasma, i.e., result in a hydrophobic surface.
- an oxidizing acid such as nitric acid, or nitric acid in combination with hydrogen peroxide. This flush will oxidize the surface and result in a hydroxyl layer similar to oxygen plasma, i.e., result in a hydrophobic surface.
- a remainder 112 of the inner surface 113 in the figures is hydrophilic or neither hydrophilic nor hydrophobic, i.e., a neutral hydrophile.
- a “remainder” of the inner surface is substantially all of the inner surface that is not hydrophobic.
- a plasma such as CF 4 or C 2 H 2 or a combination thereof.
- Such plasmas can create a surface with CF x bonds on the surface that are hydrophilic. Coupling this with micron scale or nano scale roughness can result in a superhydrophobic surface.
- the hydrophobic tube end can also be achieved by assembling a hydrophobic tube onto the end of the device. This hydrophobic tube can be retained by the soft outer tube with an interference fit.
- the length of the tube collector should be enough to collect all tear in an eye when its entrance is in contact with the tear for a desirable short period of time, such as from a few seconds to a day.
- a typical length can range from sub-millimeters to a few meters.
- the interior surface of the tube collector can be entirely hydrophilic.
- the water contact angle of the interior surface can range from a few degrees to 90 ⁇ 20 degrees so that the meniscus force of the tear inside the tube will dominate the tear flow into the tube. At these small scales, the result is a strong suction mechanism for tear fluid to go inside the tube.
- the short-term tube embodiment can be taken to have three or so parts: a hydrophilic tube to pull liquid into the tube, a hydrophobic end to allow air to exit and retain liquid, and a soft outer coating that may be used on the hydrophilic tip placed in contact with the eye, or throughout the whole tube.
- the inner diameter of the tube can have a range from 1 ⁇ m-1 mm.
- the diameter of the tube along with the contact angle is used to determine the suction force:
- the flow rate, Q, through the tube is given by:
- the largest inner radius for the short-term tear collector for the device is:
- FIGS. 2 A-B illustrate a tear secretion flow measurement device having silicone rubber just at its tip.
- Device 200 includes biocompatible capillary tube 206 having entrance end 202 and exit end 204 . Its inner diameter 210 and length 220 can have the same ranges as in the previous embodiment.
- inner surface 213 Inside the capillary tube is inner surface 213 , extending to the entrance area, but not necessarily including an inner surface created by silicone rubber covering 218 .
- Exit end 204 has localized hydrophobic inner surface 214 extending a length 216 from exit end 204 .
- the balance of inner surface 213 is hydrophilic or has neutral hydrophilicity.
- FIG. 3 illustrates a bypass channel to a tear secretion measurement device.
- Device 300 includes capillary tube 306 with entrance end 302 and exit end 304 .
- Inner surface 312 is mostly hydrophilic or a neutral hydrophile, and a small, localized inner surface 314 near exit end 304 is hydrophobic.
- Larger tube 334 encompasses capillary tube 306 , forming bypass channel 332 extending from entrance end 302 around an outside of capillary tube 306 to exit end 304 .
- the ratio of the internal areas of internal tube 306 and larger tube 334 are selected so that a certain, predetermined ratio of liquid bypasses capillary tube 306 in bypass channel 332 . For example, only 10% of the liquid flowing into the entrance of the larger tube may flow into capillary tube 306 , leaving 90% to bypass it.
- the bypass channel is created through a tube that is about the same size as the sampling capillary tube or non-tube structure.
- a non-tube structure can include a micromanufactured rectangular channel.
- a bypass channel may help with devices that are left in the eye for long periods of time.
- a long-term tear collecting device's fiber-like geometry can be straight, curved, winding/twisting, etc. depending on its placement.
- the microcapillary tube should have a curvature matching the curvature of the eyeball if it is placed inside the inferior eyelid for a few hours to a few months.
- the tube can also have a winding/twisting geometry to wrap around a punctal plug that will be inserted inside the punctal canal, and the tube will collect only a portion of the total tear going through both the punctal pug and the tube.
- the tube should have a diameter to collect a portion of the total tear inside the inferior eyelid or through the punctal canal long-term wise in an eye, depending on the tear-collecting time.
- a typical diameter can range from 10-3,000 ⁇ m.
- the length of the tube collector should be enough to collect the desirable portion of the all tear fluid inside the inferior eyelid or through the punctal canal.
- a typical length can range from sub-millimeters to a few meters.
- the interior surface of the tube collector is of neutral, that is, neither hydrophobic nor hydrophilic. This is a significant difference from the short-term tear collector.
- the water contact angle of the interior surface should be about 90 ⁇ 20 degrees so the meniscus force of the tear inside would be minimal and, therefore, only tear pressure from outside the entrance will push the tear to flow inside the tube collector.
- the whole tube including both ends of the entrance and exit, can be coated with a soft material, including but not limited to collagen or soft silicone, to ensure eye comfort.
- a soft material including but not limited to collagen or soft silicone
- One end of the tube may be blocked with hydrophobic material.
- the tube can also have a “lid” so after removal of tube the fluid inside does not evaporate.
- the tube can be replaced in a bag to further reduce the evaporation of the fluid from within the tube, whether the tube has a lid or not.
- the tear liquid trapped inside either the long-term and short-term tear collectors can be measured by the device's weight change from an empty state. This would work especially well for the short-term tear collector. However, it may also be adequate to have a simple optical reader to measure the position of the meniscus inside the tear collector, which can be converted to the total volume of the tear, especially for the long-term collector.
- both the long-term and short-term tear collector can be stored inside a sealed container so that the tear liquid will not evaporate and can be saved for future measurement and analysis.
- the reader can also read the various analytes and osmolarity of the tear fluid.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Optics & Photonics (AREA)
- Hydrology & Water Resources (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Fluid Mechanics (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
where F is the force, p is the pressure, r is the radius, γ is the liquid-air surface tension, and 0 is the contact angle. For a tube with a circular cross section, its hydraulic resistance is given by:
Claims (16)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18/344,118 US12239374B2 (en) | 2019-02-15 | 2023-06-29 | Method of manufacturing a tear flow measurement device |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806182P | 2019-02-15 | 2019-02-15 | |
| US16/786,377 US11730358B2 (en) | 2019-02-15 | 2020-02-10 | Tear flow measurement device |
| US18/344,118 US12239374B2 (en) | 2019-02-15 | 2023-06-29 | Method of manufacturing a tear flow measurement device |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/786,377 Division US11730358B2 (en) | 2019-02-15 | 2020-02-10 | Tear flow measurement device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20230337906A1 US20230337906A1 (en) | 2023-10-26 |
| US12239374B2 true US12239374B2 (en) | 2025-03-04 |
Family
ID=72043126
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/786,377 Active 2041-12-08 US11730358B2 (en) | 2019-02-15 | 2020-02-10 | Tear flow measurement device |
| US18/344,118 Active US12239374B2 (en) | 2019-02-15 | 2023-06-29 | Method of manufacturing a tear flow measurement device |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/786,377 Active 2041-12-08 US11730358B2 (en) | 2019-02-15 | 2020-02-10 | Tear flow measurement device |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US11730358B2 (en) |
| WO (1) | WO2020167649A1 (en) |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849368A (en) * | 1995-02-01 | 1998-12-15 | Schneider (Usa) Inc | Process for hydrophilicization of hydrophobic polymers |
| US6186974B1 (en) * | 1997-01-10 | 2001-02-13 | University College London And Moorfields Eye Hospital Nhs Trust | Device for use in the eye |
| US20020198453A1 (en) * | 2001-06-11 | 2002-12-26 | Herrick Family Limited Partnership | Implant capable of forming a differential image in an eye and methods of inserting and locating same |
| US20060188410A1 (en) * | 2005-02-22 | 2006-08-24 | Maruishi & Co., Ltd. | Sample fluid collecting device |
| US20110151432A1 (en) * | 2008-07-16 | 2011-06-23 | Boston Microfluidics | Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow |
| US20140342371A1 (en) * | 2012-12-05 | 2014-11-20 | Theranos, Inc. | Bodily Fluid Sample Collection and Transport |
| US20160349153A1 (en) * | 2011-04-19 | 2016-12-01 | Porex Corporation | Liquid Sampling, Storage, Transfer and Delivery Device |
| US20160367806A1 (en) * | 2015-06-16 | 2016-12-22 | The Regents Of The University Of Colorado, A Body Corporate | Nasolacrimal implants and related methods for tear stimulation |
| US20160374648A1 (en) * | 2015-06-26 | 2016-12-29 | Koninklijke Philips N.V. | Wearable device and method for collecting ocular fluid |
| US20180104514A1 (en) * | 2016-10-14 | 2018-04-19 | Olympic Ophthalmics, Inc. | Therapeutic ultrasound for eye disorder |
| US20180292368A1 (en) * | 2015-12-18 | 2018-10-11 | Roche Diagnostics Operations, Inc. | Automated clinical diagnostic system and method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3861396A (en) * | 1973-08-08 | 1975-01-21 | Hydro Med Sciences Inc | Drainage tube |
| US4531943A (en) * | 1983-08-08 | 1985-07-30 | Angiomedics Corporation | Catheter with soft deformable tip |
| US4635488A (en) | 1984-12-03 | 1987-01-13 | Schleicher & Schuell, Inc. | Nonintrusive body fluid samplers and methods of using same |
| EP2583628B9 (en) * | 2011-10-17 | 2016-09-07 | OPIA Technologies | Device and method for sampling tear fluid |
| KR101571467B1 (en) | 2014-11-21 | 2015-11-24 | 한국과학기술연구원 | Apparatus for collecting tear |
-
2020
- 2020-02-10 WO PCT/US2020/017480 patent/WO2020167649A1/en not_active Ceased
- 2020-02-10 US US16/786,377 patent/US11730358B2/en active Active
-
2023
- 2023-06-29 US US18/344,118 patent/US12239374B2/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5849368A (en) * | 1995-02-01 | 1998-12-15 | Schneider (Usa) Inc | Process for hydrophilicization of hydrophobic polymers |
| US6186974B1 (en) * | 1997-01-10 | 2001-02-13 | University College London And Moorfields Eye Hospital Nhs Trust | Device for use in the eye |
| US20020198453A1 (en) * | 2001-06-11 | 2002-12-26 | Herrick Family Limited Partnership | Implant capable of forming a differential image in an eye and methods of inserting and locating same |
| US20060188410A1 (en) * | 2005-02-22 | 2006-08-24 | Maruishi & Co., Ltd. | Sample fluid collecting device |
| US20110151432A1 (en) * | 2008-07-16 | 2011-06-23 | Boston Microfluidics | Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow |
| US20160349153A1 (en) * | 2011-04-19 | 2016-12-01 | Porex Corporation | Liquid Sampling, Storage, Transfer and Delivery Device |
| US20140342371A1 (en) * | 2012-12-05 | 2014-11-20 | Theranos, Inc. | Bodily Fluid Sample Collection and Transport |
| US20160367806A1 (en) * | 2015-06-16 | 2016-12-22 | The Regents Of The University Of Colorado, A Body Corporate | Nasolacrimal implants and related methods for tear stimulation |
| US20160374648A1 (en) * | 2015-06-26 | 2016-12-29 | Koninklijke Philips N.V. | Wearable device and method for collecting ocular fluid |
| US20180292368A1 (en) * | 2015-12-18 | 2018-10-11 | Roche Diagnostics Operations, Inc. | Automated clinical diagnostic system and method |
| US20180104514A1 (en) * | 2016-10-14 | 2018-04-19 | Olympic Ophthalmics, Inc. | Therapeutic ultrasound for eye disorder |
Also Published As
| Publication number | Publication date |
|---|---|
| US20200260946A1 (en) | 2020-08-20 |
| WO2020167649A1 (en) | 2020-08-20 |
| US20230337906A1 (en) | 2023-10-26 |
| US11730358B2 (en) | 2023-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhu et al. | Lab‐on‐a‐Contact lens: Recent advances and future opportunities in diagnostics and therapeutics | |
| DE69828351T2 (en) | Polymer molded article having a hydrophilic surface and process for its preparation | |
| EP1617757B1 (en) | Devices for collecting analytes of interest in tears | |
| US8713997B2 (en) | Systems and methods for collecting tear film and measuring tear film osmolarity | |
| US11213203B2 (en) | Implantable micro-fluidic device for monitoring of intra-ocular pressure | |
| US8585630B2 (en) | Implantable intraocular pressure drain | |
| US20140227437A1 (en) | Accommodating intraocular lens | |
| US10219696B2 (en) | Implantable pressure sensors for telemetric measurements through bodily tissues | |
| US20150202082A1 (en) | Ferromagnetic valves | |
| US6371122B1 (en) | Gauge/dilator apparatus | |
| CA2621993A1 (en) | Glaucoma treatment devices and methods | |
| AU2004296205A1 (en) | Glaucoma implant device | |
| US12239374B2 (en) | Method of manufacturing a tear flow measurement device | |
| KR20160086767A (en) | Accommodating intraocular lens | |
| Ten Hulzen et al. | Effect of fixation pressure on juxtacanalicular tissue and Schlemm's canal. | |
| WO2020214802A1 (en) | Ultra-sharp microneedle | |
| US10492945B2 (en) | Small molecule transport device with anti-condensation filler for drug delivery or waste removal | |
| EP1782763A1 (en) | Iris fixated intraocular lens | |
| WO2014093875A1 (en) | System and method to locally deliver therapeutic agent to inner ear | |
| AU2023236011A1 (en) | Astigmatism correcting contact lenses | |
| EP3015874A1 (en) | Systems and methods for collecting tear film and measuring tear film osmolarity | |
| WO2013038309A1 (en) | Intraocular lens | |
| JP4833230B2 (en) | Sample injector | |
| McCarey et al. | Gentamicin diffusion across hydrogel bandage lenses and its kinetic distribution on the eye | |
| DE102006027051A1 (en) | Sensor and method for measuring the concentration of components in a liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: UNIVERSITY OF SOUTHERN CALIFORNIA, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HUMAYUN, MARK S.;REEL/FRAME:064113/0917 Effective date: 20200117 Owner name: CALIFORNIA INSTITUTE OF TECHNOLOGY, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAI, YU-CHONG;SCIANMARELLO, NICHOLAS E.;SIGNING DATES FROM 20200131 TO 20200207;REEL/FRAME:064113/0696 |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |